Article
Novel Treatment Strategies in the Management of Waldenström Macroglobulinemia.
Current hematologic malignancy reports - 1 Feb 2020
Zanwar Saurabh, Abeykoon Jithma Prasad, Kapoor Prashant
Abstract excerpt
PURPOSE OF REVIEW: Recent advances the genomic profiling of patients with Waldenström macroglobulinemia (WM) have led to the identification of novel therapeutic targets in these patients. In this review, we cover the current standard of care and the recently evaluated novel approaches with high potential to be incorporated in the therapeutic armamentarium against WM. RECENT FINDINGS: The MYD88L265P mutation is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
